Clinical Trials Logo

Anaphylaxis Food clinical trials

View clinical trials related to Anaphylaxis Food.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03487315 Completed - Wheat Allergy Clinical Trials

Major Allergen in Wheat Anaphylaxis in Thai Population

Start date: April 5, 2017
Phase: N/A
Study type: Interventional

- To study Major allergen in Wheat anaphylaxis in Thai population - To study and compare demographic data between group of wheat anaphylaxis

NCT ID: NCT03149315 Completed - Food Allergy Clinical Trials

Inhibition of Anaphylaxis by Ibrutinib

Start date: April 10, 2017
Phase: Phase 2
Study type: Interventional

This is a phase II open label study on the use of Ibrutinib on the inhibition of food-induced anaphylaxis in adults with food allergy. Ibrutinib (brand name Imbruvica) is currently FDA approved for the treatment of mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and Waldenstrom's macroglobulineia (WM). We propose to administer this approved drug to adults with food allergy to inhibit food allergy responses.